These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8298232)

  • 21. Modified pharmacokinetic modulating chemotherapy using 5-fluorouracil, UFT, and taxotere (docetaxel) for advanced gastric cancer.
    Tanaka K; Konishi N; Ohmori Y; Kobayashi M; Mohri Y; Tonouchi H; Kusunoki M
    Int J Clin Oncol; 2003 Dec; 8(6):381-5. PubMed ID: 14663641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
    Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
    Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of advanced gastric cancer (Borrmann's type 2) that disappeared following short-term preoperative chemotherapy with UFT].
    Uesugi H; Azuumi Y; Saigenji K; Okabe H; Mieno H; Motoori T
    Gan No Rinsho; 1989 Jul; 35(8):963-9. PubMed ID: 2501536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy for high-grade advanced gastric cancer.
    Yonemura Y; Sawa T; Kinoshita K; Matsuki N; Fushida S; Tanaka S; Ohoyama S; Takashima T; Kimura H; Kamata T
    World J Surg; 1993; 17(2):256-61; discussion 261-2. PubMed ID: 8511923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten-year survival of curability B gastric cancer patients treated by tegafur-uracil as postoperative adjuvant chemotherapy in a common public hospital: univariate and multivariate analyses.
    Okuyama T; Higashi T; Edagawa A; Nagata S; Hashimoto K; Saeki H; Oki E; Uchiyama H; Kawanaka H; Morita M; Tateishi M; Korenaga D; Yaita H; Takenaka K
    Fukuoka Igaku Zasshi; 2012 Jul; 103(7):138-44. PubMed ID: 22978066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of long-term administration of oral anti-cancer agent].
    Watanabe H; Sakakibara N
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):637-42. PubMed ID: 8470922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.
    Zhao WH; Wang SF; Ding W; Sheng JM; Ma ZM; Teng LS; Wang M; Wu FS; Luo B
    World J Gastroenterol; 2006 Mar; 12(9):1356-61. PubMed ID: 16552801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
    Saka M; Sasako M; Katai H; Sano T
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized study with mitomycin C + 5-fluorouracil+cytosine arabinoside (MFC)+5-fluorouracil, MFC+tegafur and uracil (UFT), and MF+UFT in advanced gastric cancer: interinstitutional differences in a multicenter study in Japan.
    Furukawa H; Iwanaga T; Nakajima T; Okabayashi K; Nakazato H; Hiratsuka M; Ohta K; Kito T; Yamamura Y; Goto S
    J Surg Oncol; 1995 Sep; 60(1):59-64. PubMed ID: 7666668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case report of adenosquamous cell carcinoma of the stomach responding well to combination chemotherapy].
    Tenma K; Nakamura T; Kano T; Suzuki T; Ohashi Y; Masaoka T; Sato K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):647-50. PubMed ID: 8470924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of resected gastric cancer in which cancer had apparently disappeared by preoperative administration of tegafur].
    Jyoujima Y; Kono T; Sawano M; Shimoyama S; Kubota K; Shimada T; Nakahama M; Nakamura T; Ogawa T; Chin H
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1275-8. PubMed ID: 8031172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case report of long-term survivor of advanced gastric cancer associated with peritoneal dissemination successfully treated with cancer chemotherapy].
    Shibata N; Tamai M; Ikeda K
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):119-22. PubMed ID: 7826066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin.
    Suga S; Iwase H; Shimada M; Nishio Y; Ichihara T; Ichihara S; Kusugami K; Saito H
    Intern Med; 1996 Dec; 35(12):930-6. PubMed ID: 9030989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological indications of a favorable prognosis with far-advanced gastric carcinomas after preoperative chemotherapy.
    Ninomiya Y; Yanagisawa A; Kato Y; Kitagawa T; Ishihara S; Nakajima T
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):699-706. PubMed ID: 10592104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
    Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U
    Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of advanced gastric carcinoma with disappearance of cancer cells by neoadjuvant chemotherapy].
    Nakagawachi T; Yunotani S; Nakamura M; Samejima R; Shida T; Yonemitsu N; Eguchi T; Miyazaki K
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1955-8. PubMed ID: 9797819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CDDP.UFT therapy for advanced or metastatic gastric cancer].
    Tadaoka N; Takayama S; Sekine C; Fujimori T; Nimura H; Tsutsumi J; Kashimura H; Sano Y; Hirai K; Aoki T
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1257-9. PubMed ID: 8333755
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adjuvant chemotherapy after curative resection for gastric cancer-5'-DFUR + cisplatin vs 5'-DFUR].
    Fujitani K; Kobayashi K; Tamaki Y; Tsujinaka T; Hirao M
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):61-5. PubMed ID: 11816479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.